EPISODE · Jun 9, 2022 · 37 MIN
4.67 Teclistimab for R/R Multiple Myeloma
from Plenary Session - inactive due to federal service · host Vinay Prasad, MD MPH
The drug has a high response rate and lots of infections, is it active? Yes; Efficacious? ???? I review ASCO2022 updates
Embed this episode
NOW PLAYING
4.67 Teclistimab for R/R Multiple Myeloma
0:00
37:42
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Plenary Session - inactive due to federal service?
This episode is 37 minutes long.
When was this Plenary Session - inactive due to federal service episode published?
This episode was published on June 9, 2022.
Can I download this Plenary Session - inactive due to federal service episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!